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Abstract 
The effect of macromolecules on the crystallization 
in solutions with an ion-composition and a pH corre-
sponding to that of urine in the distal part of the distal 
tubuli was examined by recording the number and vol-
ume of crystals in a Coulter Multisi:zer and by studying 
the crystal morphology with scanning electron micros-
copy at different degrees of evaporation. The experi-
ments were carried out with 100 ml samples of salt so-
lutions with and without different concentrations of 
dialysed urine (dU) from normal subjects. Addition of 
dU resulted in a greater number of crystals and a reduc-
tion in the mean crystal volume (MCV). Under the ex-
perimental conditions, the maximal effect of the macro-
molecules appeared to be accomplished in solutions with 
an initial dU concentration of 10 % . 
The precipitate was strongly suggestive of calcium 
phosphate (CaP) as shown by scanning electron micros-
copy and Raman spectroscopy. This conclusion was fur-
ther supported by the ion-activity products of calcium 
oxalate (CaOx) and different CaP salts in those samples 
in which crystal formation was recorded. The obtained 
results give support to the view that macromolecules 
might exert a promotive effect on the nucleation of CaP. 
The macromolecules also appear to counteract the devel-
opment of large CaP crystals, but whether this is due to 
an inhibition of crystal growth, an inhibition of crystal 
aggregation or both could not be concluded from these 
experiments. The way in which CaP crystals initially 
form in the nephron might be of importance for the sub-
sequent crystallization of CaOx and the formation of 
CaOx containing stones. 
Key Words: Crystallization, calcium phosphate, distal 
tubule of the nephron, promotion, inhibition, urinary 
macromolecules. 
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Introduction 
Although calcium stones formed in the upper uri-
nary tract have calcium oxalate (CaOx) as the dominant 
constituent, the majority of such stones are mixtures of 
CaOx and CaP (Pak et al., 1971; Chambers et al., 
1972; Prien, 1975; Leusmann et al., 1990). It has fur-
thermore been shown that patients who developed stones 
with a high fraction of CaP had more frequent stone re-
currences than those with a low content of CaP (Larsson 
et al., 1984a,b; Tiselius and Larsson, 1993). In a 
recent experimental study, we have shown that CaP was 
the type of crystal that most easily formed in the prox-
imal and distal tubuli when the concentration of calcium 
was increased (Luptak et al. , 1994). 
This brings into focus the important question: 
whether mixed calcium stones might be a result of a pri-
mary nucleation of CaP followed by a heterogeneous 
deposition of CaOx crystals. Although such a model 
previously bas been proposed by several authors (Pak, 
1969; Pak et al., 1971; Nancollas, 1983), the role of 
CaP to a great extent has been ignored in favour of 
CaOx, attributable to the pronounced influence that oxa-
late has in changing the supersaturation of urine. 
It is generally accepted that low molecular weight 
molecules such as citrate, magnesium and pyrophosphate 
have inhibitory influences on the crystallization of both 
Ca Ox and CaP, but the macromolecules might be of 
even greater importance for the crystallization process 
(Coe et al., 1980; Resnick et al., 1982; Nakagawa et 
al., 1983; Rose, 1984; Nakagawa et al., 1985; Ryall et 
al., 1985; Tiselius et al., 1987; Hess et al., 1989) 
Most studies on the crystallization of CaOx and CaP 
have been carried out in solutions with a composition 
similar to that in urine from normal subjects or stone 
formers. This makes the interpretation difficult as it is 
reasonable to assume that the important pathophysiologic 
processes occur at a higher level of the nephron where 
the urine composition is different from that in final 
unne. 
In an attempt to increase our understanding of the 
initial steps of the crystallization during formation of 
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mixed calcium stones, we have studied the influence of 
different concentrations of macromolecules on the crys-
tallization process in solutions with an ion-composition 
corresponding to that in the distal tubuli. 
Material and Methods 
A salt solution with an ion-composition assumed to 
correspond to that of urine in the distal part of the distal 
tubuli (DTd) was prepared as previously described 
(Luptak et al. , 1994). In this solution the ion-composi-
tion was as follows : 1.04 mM calcium, 0.41 mM mag-
nesium, 4.17 mM phosphate, 0.04 mM oxalate, 0.35 
mM citrate, 96.0 mM sodium, 22.5 mM potassium and 
13.8 mM sulfate. No ammonium was added to avoid 
the risk of precipitation of ammonium salts. 
The pH was measured with a glass electrode (pHM 
84; Radiometer, Copenhagen, Denmark) and adjusted to 
6.45 (Rector, 1983) immediately before and after evapo-
ration of 100 ml samples with and without dialysed urine 
(dU). Because pH declined with increasing degree of 
evaporation, we also measured the pH in salt solutions 
without calcium but otherwise with the same concentra-
tions of ions as in the standard DTd solution. These 
measurements were undertaken in order to record pH 
changes that occurred as a result of volume reduction 
but not associated to the precipitation of calcium salts. 
Pooled dU from normal subjects was used as a 
source of macromolecules. This urine was collected be-
tween 2200 and 0600 hours. The urine was screened for 
the presence of bacteria, protein and glucose before 
being included in the pool. The pooled urine was subse-
quently centrifuged at 2800 rpm for 30 minutes after pH 
adjustment to 5.8. The supernatants were decanted and 
saved, and the sediments were combined in one tube. 
Following repeated centrifugation of the sediment frac-
tion, this supernatant was combined with the previously 
collected supernatants. The crystals in the sediment 
were dissolved by addition of 1 mM HCI. After centrif-
ugation and neutralisation, this supernatant was com-
bined with the other urine. The undissolved material in 
the tube was discarded. The pH of the urine was then 
readjusted to 5.8 . One hundred milliliter aliquots of the 
pooled urine were then transferred to Spectrapore No. 3 
dialysis tubings with an exclusion limit of 3500 Daltons 
(D) (Spectrum Medical Industries, Inc., Houston, TX). 
The aim was to get a source of macromolecules with a 
wide range of molecular weights. Each tubing was 
placed in 1000 ml of deioniz.ed water with magnetic stir-
ring at room temperature. The water was exchanged 
eight times, once every hour. During the following 15 
hours, still under continuous stirring, the samples were 
kept in deioniz.ed water at 4 °C, after which the deion-
iz.ed water was replaced by Milli-Q filtered water (Milli-
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pore, S.A., Molsheim, France), exchanged six times, 
once every hour. The samples were subsequently filled 
up to the original volume with water and stored at -20°C 
until used in the experiments. Samples of salt solutions 
with different concentrations of macromolecules were 
subsequently used in the experiments. According to the 
concentration of urine in the distal tubuli, the normal 
concentration of macromolecules at that level was 
assumed to approximately correspond to that in a 20 % 
solution of dU. 
Samples of 100 ml salt solutions without and with 
different concentrations of dU were passed through Mil-
lipore filters with a pore size of 0.22 µm (Millipore 
S.A.) before evaporation in a Biichi Rotavapor RE 
(Flawil, Switzerland) at 37°C. 
After evaporation to a predetermined solution vol-
ume, the number and volume of crystals in the size in-
terval 2.4 to 45 µ,m were recorded in a Coulter Multi-
sizer with a 100 µm capillary tube (Coulter Electronic 
Ltd., Luton, U .K.). Recordings were carried out both 
immediately after the evaporation and after 60 minutes 
of continuous agitation in an incubator at 37°C. The 
mean crystal volume (MCV) was calculated as the quo-
tient between the total volume (µm3) and the total 
number of crystals. 
For studies of crystal morphology, aliquots of 0.5 
ml obtained immediately after the evaporation had been 
completed were passed through polycarbonate membrane 
filters with a pore size of 0.2 µm (Poretic Corp., Liv-
ermore, CA) . The filters were rinsed with air, mounted 
with double stick tape on metallic stubs and dried at 
room temperature. The crystals were subsequently cov-
ered by a 10 nm layer of metallic platinum in an 
Edwards (Edwards High Vacuum, Crawley, Sussex, 
U.K.) model 3AM twin electron beam gun sputter coat-
ing unit. The crystals were examined in a JEOL 
(Tokyo, Japan) JSM-840 scanning electron microscope. 
Crystal material formed in solutions with final 
volumes around 35, 15 and less than 10 ml was centri-
fuged at 1500 rpm for 15 minutes and the sediments 
were dried at room temperature. Raman spectroscopy, 
using a IFS 106 (Brucker Instruments, Billerica, MA) 
unit connected to a Brucker 66V fourier transform spec-
trometer, was performed on this material to qualitatively 
examine if it contained CaOx or CaP. The Raman ef-
fect is based on the inelastic scattering of photons when 
a monochromatic light interacts with the matter. 
The concentration of ions in solutions with volumes 
of 100, 90, 80, 70, 60, 50, 40, 30, 20 and 10 ml, corre-
sponding to the volume reduction brought about by evap-
oration, were used for calculating the ion-activity pro-
ducts of calcium oxalate (APcaoJ, calcium hydrogen 
phosphate, brushite (AP8Ru), hydroxyapatite (APuAP), 
amorphous calcium phosphate (AP Acp), and octacalcium 
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Figure 1. Relationship between the pH and the sample volume after evaporation of 100 ml solutions without dialysed 
urine( ■), with 20% of dialysed urine (O), and without both dialysed urine and calcium ( + ). 
phosphate (APocp)- For ACP, we used the approximate 
formula Ca(PO4)0_74(H\)_22 (Christoffersen et al., 1990). 
The ion activity products were calculated by means of 
computerized iterative approximation with the EQUIL2 
program (Wemess et al., 1985). The pH values used in 
the calculations were those measured at the different de-
grees of evaporation because there was no difference in 
pH between solutions with and without calcium (Fig. 1). 
The concentration of carbon dioxide in our samples was 
not measured despite the fact that it certainly was re-
duced as a result of the evaporation. Under the compo-
sitional conditions in our system, the effects of carbon 
dioxide on the ion-activities of calcium, phosphate and 
oxalate appeared to be of minor importance. For this 
reason, we set this concentration to z.ero in all EQUIL2 
computations. Complex formation between ions and uri-
nary macromolecules were not accounted for in our cal-
culations. Although macromolecules form complexes 
with ions in urine (Sheinfeld et al., 1978; Morse and 
Resnick, 1989; Nishio et al., 1990), their effects in our 
experimental system are difficult to predict. Sheinfeld 
et al. (1978) showed that the concentration of calcium in 
urine was reduced by approximately 9 % following ultra-
filtration, that of phosphate by 12 % and that of oxalate 
by 13 % . In addition, there might be a reduced ion 
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strength brought about by a binding also of sodium and 
other ions. Attributable to the low concentration of 
macromolecules, the ion-activities in the solutions at the 
start of the evaporation were probably not more than a 
few percent lower than those prospected from our calcu-
lations. During the evaporation, the effect of macromol-
ecules might be more important as their relative con-
centrations increase. We have, therefore, most certainly 
overestimated the different ion-activity products at the 
end-point of the evaporation. Although it is possible to 
measure the ion-concentration of calcium directly in the 
samples and in this way get information on the complex-
ation with macromolecules, such measurements are not 
useful after the evaporation when the ion-concentration 
is affected not only by the complexation with macro-
molecules but also by the precipitation. We believe, 
however, that the simplification introduced by ignoring 
the effects of macromolecules in no way has influenced 
our conclusions. 
Formation of crystals was not considered to have 
occurred until the number of particles in a 100 µI aliquot 
exceeded 100. This level was chosen to minimise the 
risk of counting non-crystal material, since a distinction 
between crystals and other particles was not possible in 
the Coulter equipment. Based on previous microscopic 
I. H0jgaard et al. 
4 
3.5 □ • 
3 
'" • . o ~ 0 
~ 2.5 • • • s o• = C 
3 
"' 2 ..., 0 '" "' ■ OJ) 
0 




0 1 0 20 30 40 50 60 70 80 90 100 
Sample volume after evaporation, ml 
Figure 2. Relationship between the number of crystals and the sample volume after evaporation of 100 ml solutions 
with an initial composition corresponding to that in the distal tubuli . The evaporation was carried out of samples 
without dialysed urine( ■) or with dialysed urine in concentrations of 5% ( □), 10% (•) and 20% (O). 
-----------------------------------------------------------------------------------------------
observations, a nucleation is conceivable when 100 
crystals has formed. 
Statistical analysis 
Regression analysis was carried out to record any 
association between different variables and Student's 
t-test was used to decide on statistical significance. 
Results 
Crystal number 
There was a linear relationship between the 1°tog 
crystal number and the degree of evaporation of solu-
tions without and with dU in concentrations of 5 % , 10 % 
and 20% (Fig. 2). The coefficients of correlation were 
all statistically significant (p < 0.001), both for samples 
analysed immediately after evaporation and for those 
analysed after 60 minutes (Table 1). As shown in Fig-
ure 1, the slopes of the different regression lines were 
almost parallel in the four series of experiments, and it 
is evident that in the salt solution without dU, the num-
ber of crystals was below the critical limit of 100 until 
the solution volume had been reduced to 15 ml. With 
5 % of dU, this limit was already reached at a volume of 
55 ml and at a volume of 80 ml in the presence of 10 % 
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of dU. There were no major differences between the 
samples containing 10% and 20% of dU in terms of the 
number of crystals formed during evaporation. 
There were no obvious differences in the relation-
ship between the 10log crystal number and the degree of 
evaporation between the crystal counts after 0 and 60 
minutes, but there was a tendency towards a smaller 
number of crystals in the 60 minute samples containing 
10% and 20% of dU. 
Mean crystal volume 
Although less pronounced than the relationship be-
tween the volume reduction and the crystal number, 
there was also a significant correlation (p < 0.025) 
between the degree of evaporation and the MCV in sam-
ples analysed immediately after the evaporation (Table 
1), and the relationship between the degree of evapora-
tion and the 10log MCV is shown in Figure 3. It is evi-
dent that, whereas the MCV became greater as the vol-
ume of solutions without dU was decreased, the opposite 
was found for solutions with dU. This effect was most 
pronounced at the highest concentrations of dU. Similar 
to the recorded crystal number, there were no major dif-
ferences in MCV between samples containing 10% and 
20% of dU. 
Crystallization in the distal tubule 
Table 1. The number of crystals and the mean crystal volume (MCV) in solutions without and with different 
concentrations of dialysed urine (dU). 
Salt Coefficient of Slope p value Number of 
solution correlation experiments 
Immediately After Immediately After Immediately After 
after 60 after 60 after 60 
evaporation minutes evaporation minutes evaporation minutes 
Number of crystals 
without dU 0.78 0.64 0.0138 0.0105 < 0.001 < 0.001 60 
with 5% dU 0.85 0.82 0.0163 0.0166 < 0.001 < 0.001 93 
with 10% dU 0.92 0.86 0.0199 0.0159 < 0.001 < 0.001 85 
with 20% dU 0.89 0.91 0.0212 0.0164 < 0.001 < 0.001 90 
MCV 
without dU 0.310 0.150 0.0046 0.0021 < 0.025 > 0.05 60 
with 5% dU 0.280 0.040 -0.0044 -0.0007 < 0.01 > 0.05 93 
with 10% dU 0.470 0.360 -0.0060 -0.0053 < 0.001 < 0.001 85 
with 20% dU 0.510 0.180 -0.0075 -0.0024 < 0.001 > 0.05 90 
DTd DTd5% dU. 
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3 
■ 
3 D c0 
;;,. 2.5 ~-f-':t-·.. ., ■ ;;,. 2 .5 u u ::;; 2 ::;; 2 
Qi) Oil j 1.5 .. ■ ■ .. ■ .. j 1.5 
<: 1 <: 1 ,.. .... 
0 .5 0 .5 
0 0 
0 20 40 60 80 100 0 20 40 60 80 100 
Sample volume after evaporation, ml Sample volume after evaporation, ml 
DTd 10% dU. DTd20% dU. 
3.5 3.5 
3 ., 3 ~ ;;,. 2.5 ;;,. 2.5 u • • ... ·!, u ::;; 2 ::;; 2 
Oil ~.,. .. ._,. ..,..,,: ., .. Oil j 1.5 j 1.5 
<: 1 • <: 1 0 ,.. .... c9 0 .5 0 .5 0 
0 0 
0 20 40 60 80 100 0 20 40 60 80 100 
Sample volume after evaporation, ml Sample volume after evaporation, ml 
Figure 3. Relationship between the MCV and the sample volume after evaporation of 100 ml solutions with an initial 
composition corresponding to that in the distal tubuli. The evaporation was carried out of samples without dialysed 
urine (DTd) or with dialysed urine in concentrations of 5% (DTd 5% dU), 10% (DTd 10% dU) and 20% (DTd 20% 
dU) of dialysed urine. 
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Table 2. The ion-activity products at different volume after evaporation of 100 ml samples of salt solutions without 
dialysed urine (dU) and with a starting pH of 6.45. 
volume pH AP APACP 
after 8 
Caox
2 1012 X M2 10 x M 
evaporation 
100 ml 6.45 0.15 1.79 
90 ml 6.44 0.17 1.77 
80 ml 6.42 0.19 1.75 
70 ml 6.40 0.22 1.74 
60 ml 6.37 0.26 1.73 
50 ml 6.35 0.31 1.78 
40 ml 6.32 0.41 1.89 
30 ml 6.27 0.56 1.94 
20 ml 6.16 0.90 3.09 
10 ml 5 .98 1.96 7.05 
Crystal morphology 
Examination of the crystals with scanning electron 
microscopy showed a morphology strongly suggestive of 
CaP (Fig. 4). When samples with different concentra-
tions of dU were compared, it was evident that the num-
ber of crystals was greater in solutions containing 20 % 
of dU than in the solutions without dU. 
Raman spectroscopy 
Raman spectroscopy of the crystalline material from 
solutions reduced to volumes of 30-40 ml, 10-20 ml and 
less than 10 ml showed that it was consistent with calci-
um phosphate. No calcium oxalate was observed. 
Ion-activity products 
The saturation with CaOx remained very low until 
the solution volume had been reduced to below 20 ml 
(Table 2). With a thermodynamic solubility product for 
CaOx (SPcaox) of 0.23 to 0.25 x 10-8 M2 (Pak et al., 
1975; Tomazic and Nancollas, 1979), it is evident that 
the AP CaOx also was below this level until the volume 
had been reduced to 60 ml, in those samples the APcaox 
was 0.26 x 10-8 M2. A formation product of CaOx 
(FP caox) around 2 x 10-8 M2 was reached only at the 
most extreme degree of evaporation to 10 ml. The 
AP CaOx in all other solutions most certainly had a driv-
ing force that was too low to be associated with a nucle-
ation of CaOx, even in the presence of macromolecular 
promoters. 
As could be expected, AP ACP• APocp, APHAP and 
APBRU increased as a result of the volume reduction. 
With an SPocp of 8.3 x 10-48 M8 (Koutsoukos and Nan-
collas, 1981) and an FPocp of 2.5 x 10-45 M8 (Rob-
ertson et al., 1968), it is evident that the solutions were 
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APocr APHAP APBRU ion-
1025 X M8 1048 X M9 107 x M2 strength 
0.63 0.08 0.74 0.15 
0.80 0.17 0.85 0.16 
1.01 0.31 0.97 0. 18 
1.33 0.65 1.13 0.21 
1.79 1.36 1.35 0.24 
2.74 3.80 1.71 0.29 
4.52 11.3 2.27 0.35 
5.01 17.9 2.90 0.46 
16.9 54.6 5.30 0.68 
59.8 64.9 12.1 1.00 
highly supersaturated with respect to OCP (Table 2). 
The SPHAt has been reported to be approximately 2.35 
x 10-59 M (Koutsoukos and Nancollas, 1981) and the 
APHAP were in all samples above this level. No infor-
mation is available on FPHAP· With an SPBRU of 1.87 
x 10-7 M2 and an FPBRU of 2.0 x 10-6 M2 (Koutsoukos 
and Nancollas, 1981; Nancollas, 1982), the solutions 
were apparently undersaturated with respect to brushite 
until the volume had been reduced to less than 50 ml 
(Table 2) . The exact level of SP ACP and FP ACP are not 
known, but the recorded ACP values are close to the 
reported apparent SP of2.29 x 10-11 M2. 
Discussion 
We have previously shown that CaP is the crystal 
type that most easily forms in the proximal and distal 
tubuli when the calcium concentration is increased 
(Luptak et al., 1994). According to these results, a pos-
sible site for this crystalliz.ation in vivo is the distal part 
of the distal tubuli. Coe and Parks (1990) also have em-
phasized the importance of CaP crystalliz.ation in the ne-
phron, although their data indicated that the highest risk 
was in the loop of Henle. Irrespective of which level of 
the nephron that is responsible for the early events in the 
calcium salt precipitation, a solution with a composition 
corresponding to that in the distal part of the distal tubuli 
can be used as an experimental model for studying the 
physico-chemical crystalliz.ation properties in more de-
tail. Although an exact knowledge of the composition of 
urine at this level of the nephron is unknown, and the 
concentration of important urine variables certainly is 
subject to a considerable variation, we assume that under 
Crystallization in the distal tubule 
Figure 4. Scanning electron micrographs of the precipitate after evaporation of 100 ml salt solution, without dU (A), 
with 5% dU (B), with 10% dU (C) and with 20% dU (D), down to a volume around 35 ml. Bars = 1 µm. 
normal conditions, the ion-composition of urine in the 
distal part of the distal tubuli roughly corresponds to that 
in our salt solution with a pH of 6.45, and a concentra-
tion of macromolecules approximating that in 10 % to 
20% of dU. Dialysed bladder urine from normal sub-
jects was used as a source of macromolecules, thereby 
ignoring the fact that certain macromolecules might have 
been added to the urine as a result of its passage and 
storage in the lower parts of the collecting system, 
whereas others might have been removed during the 
preparation of dU. All macromolecules are not present 
in all parts of the nephron, but important macromolecu-
lar crystallization modifiers, such as nephrocalcin and 
Tamm-Horsfall protein, are added to the urine at levels 
above the distal part of the distal tubuli (Coe and 
Nakagawa, 1991a; Coe et al., 1991b; Hess, 1992). 
In order to measure the crystal nucleation in a Coul-
ter Counter, the solution has to be as free of particles as 
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possible. This cannot be accomplished unless the solu-
tions are filtered or centrifuged. Both these procedures 
are known to change the composition of samples con-
taining urinary macromolecules (White et al., 1983; 
Ryall et al., 1989). From this fact, it stands to reason 
that our source of macromolecules might differ in com-
position from that normally found in DTd. The most 
important difference might be in terms of Tamm-Hors-
fall protein, which is known to be adsorbed at filtration. 
The relatively high pH and the low ion-strength in the 
solution at the time of filtration will, however, counter-
act the self aggregation of the protein (Scurr and 
Robertson, 1986; Boeve et al., 1994b), a factor that 
might reduce the filter absorption. Although we are 
aware of the drawback of our sample preparation, we 
made no attempts to quantify the loss of proteins, glyco-
proteins or glycosaminoglycans. The difficulties associ-
ated with the sample preparation, however, are not 
I. H0jgaard et al. 
easily circumvented, and albeit, the composition of 
macromolecules in our samples might be different from 
that normally encountered in the nephron; the dialysed 
urine definitely contains a wide range of important 
urinary macromolecules. 
As urine moves further down the nephron from the 
distal tubuli, its composition is altered mainly by a con-
centration process, whereby the altered ion-concentra-
tions and pH might change the crystallization risk in the 
direction towards CaOx (Luptak et al., 1994). In order 
to mimic the physiological process, we followed the 
crystallization during the volume reduction accomplished 
by evaporation. Crystal formation in urine has previ-
ously been studied (Hallson and Rose, 1988) by evapora-
tion to an osmolality of 1200 mosmol/kg in which exper-
iments CaOx crystal formed at pH 5. 3 and CaP crystals 
at pH 6.7. 
In the presence of dU, the predetermined critical 
limit of 100 crystals was reached at a lower degree of 
evaporation; that is at a lower supersaturation level than 
without urine. This observation suggests that the macro-
molecules during the early phase of CaP crystallization 
act either as promoters of CaP nucleation or as modifi-
ers of CaP crystal aggregation. Although we believe 
that the most attractive interpretation of the increased 
number of crystals recorded with increasing concentra-
tions of dU is an effect on nucleation, we cannot com-
pletely rule out the possibility that this is a result of 
differences in crystal aggregation. This question can, 
however, only be solved following analysis of the size 
distribution of even the smallest crystals formed and this 
is so far not technically possible. An inhibition of crys-
tal aggregation can be expected to result in a greater 
number of crystals which grow in the supersaturated so-
lution until they attain a measurable size, whereas a pro-
motion of aggregation more rapidly will form crystal 
masses with a size that enables detection in the Coulter 
Counter. Although the MCV increased with increasing 
concentration of the urine-free solutions, the results in 
Figure 3 show a reduced MCV both with increased con-
centrations of dU and with decreased sample volumes. 
These observations apparently make crystal aggregation 
less likely as an important factor during the early stage 
of CaP crystallization, but might rather reflect a pro-
moted nucleation in combination with an inhibition of 
crystal growth. The effects of dialysed urine on the ag-
gregation of CaP crystals in solutions with a DTd com-
position is subject to further studies. 
The regression lines for the 1010g crystal number 
(Fig. 2) were almost parallel for all four series of exper-
iments, and the results with 10 % and 20 % of dU were 
almost identical. These findings indicate that the macro-
molecules under these experimental conditions had a 
maximal effect in a concentration of dU around 10 % . 
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Macromolecules isolated from calcium stones, par-
ticularly those containing gamma-carboxyglutamic acid 
have been demonstrated to have a high affinity for calci-
um ions (Lian et al., 1977; Nishio et al., 1990) and in 
the presence of urine, the number of CaOx crystals that 
formed was greater than those formed in solutions with-
out urine (Bums and Finlayson, 1980; Drach et al., 
1982; Nishio et al., 1990). Ultrafiltration of urine also 
resulted in an 85 % reduction of Ca Ox crystallization and 
the promoting effect was linked to a macromolecule with 
a molecular weight above 100 kD (Rose and Sulaiman, 
1984). A promoting effect of macromolecules on CaOx 
nucleation has been demonstrated by several groups 
(Drach et al., 1980; Yoshioka et al., 1989; Grases et 
al. , 1992). Most studies on the macromolecular promo-
tion of crystallization have been carried out in systems 
prone to CaOx crystallization. It is, however, reason-
able to assume that there is a similar mechanism for 
CaP, and that a nucleation of CaP might be induced fol-
lowing accumulation of calcium and phosphate to areas 
on macromolecules that have a specific affinity for these 
ions. Wemess and coworkers reported that HAP crys-
tals in urine were embedded in an amorphous matrix 
(W emess et al. , 19 81) and matrix protein was found to 
induce precipitation of brushite (Pak and Ruskin, 1970). 
The assumption that the precipitate in our experi-
ments consisted of CaP crystals was supported by the 
levels of the ion-activity products of calcium salts, show-
ing that the solutions were undersaturated with respect 
to CaOx but highly supersaturated with respect to ACP, 
OCP and HAP. Only at an extreme volume reduction 
might the APcaox theoretically exceed the driving force 
necessary for a heterogeneous deposition of CaOx on 
CaP (Table 2). We did not, however, detect any obvi-
ous evidence for such a crystallization in any of our 
samples. The most likely reason for this is that the pre-
cipitation of CaP starts much earlier during the evapora-
tion whereby calcium is consumed. In this way, the 
driving force is reduced and not high enough for starting 
a heterogeneous growth of CaOx on preformed crystals 
of CaP. Further evidence of the chemical nature of the 
crystals was obtained with scanning electron microscopy 
and Raman spectroscopy. 
The importance of CaP in the formation of stones 
containing CaOx and CaP has recently attracted a great 
deal of interest. Achilles et al. (1994) used a gel crys-
tallization system in which nucleated CaP spherulites 
induced heterogeneous crystallization with CaOx. Sphe-
rulites of CaP is also a common constituent of the 
nucleus of CaOx-containing stones (Blaschke and 
Schwandt, 1978; Leusmann, 1981; Khan and Hackett, 
1987) and have also been demonstrated in renal tissue 
(Meyer-Jurgens et al., 1981). The ease by means of 
which CaOx can grow on crystals of CaP has been 
Crystallization in the distal tubule 
shown by several authors (Nancollas and Gardner, 1974; 
Meyer et al., 1975, 1977; Pak, 1981; Berg and Tiselius, 
1989; Grases et al., 1989). 
Our findings support the hypothesis that nuclei of 
CaP might be the primary nidus of stones containing 
CaOx, inasmuch as CaP was the crystal type that first 
appeared during volume reduction of solutions with an 
ion-composition corresponding to that of urine in the dis-
tal part of the distal tubuli. There is evidence that mac-
romolecules of urine participate in this process, initially 
as promoters of CaP nucleation and subsequently as 
modifiers of the crystal growth and crystal aggregation. 
The principles applied in these experiments might be 
useful in further studies aimed at an increased under-
standing of the mechanisms behind calcium stone forma-
tion and in exposing any abnormalities between stone 
formers and normal subjects at urine concentrations 
relevant to the initiation of salt precipitation. 
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Disc~ion with Reviewers 
Y. Nakagawa: The authors observed a pH change in 
the solution from 6.45 to 5.95 after a 10-fold concentra-
tion. Should this be corrected to the original pH value 
of 6.45 or can this be ignored? 
Authors: As shown in Figure 1, the pH was reduced as 
a result of the volume reduction. This pH change re-
duces the supersaturation with calcium phosphate by de-
creasing the concentration of Po/- ions. A pH adjust-
ment during the volume reduction is , however, not easi-
ly accomplished without seriously interfering with the 
crystallization process. Furthermore, a combined reduc-
tion of the volume and the pH is the net effect of the 
intratubular processing of urine. The compositional 
changes that occurred in our experimental system during 
evaporation were thus considered to reflect the normal 
renal physiology; for this reason, we accepted the pH 
shift as a valuable property of our system. 
Y. Nakagawa: Small molecular weight compounds 
were eluted during dialysis of urine. Uric acid could be 
a nucleus of calcium stones. Can the authors add uric 
acid in the system? 
Authors: Although urate might possibly play a role in 
the development of calcium oxalate crystals, its contribu-
tion to the crystallization process at the concentration 
levels in this part of the nephron is doubtful. Crystals 
of uric acid will certainly not precipitate in the pH inter-
val of our experimental system and the prerequisites for 
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crystallization of sodium urate will not be met until the 
volume has been excessively reduced. We have not add-
ed urate to our system because hyperuricosuria is an un-
common finding among our calcium stone formers. The 
question is interesting in that precipitated urate might 
provide a surface for binding of macromolecules and 
thus cause an induction of calcium salt crystallization. 
S. Nishio: Did you examine the macromolecules in the 
crystals, or what kind of urinary substances (UMM) do 
you think are contained in CaP crystals made in the 
physiological concentrations of inorganic ions (Ca, P, 
Mg) and UMM? 
Authors: We made no attempts to analyse the type of 
macromolecules that were associated with the calcium 
salt precipitate. Although only speculative, it appears 
reasonable to assume that the same glycoproteins and 
glycosaminoglycans considered to be associated with the 
urinary precipitation of calcium oxalate also might take 
part in the precipitation of calcium phosphate. Further 
studies of this important question are, however, manda-
tory. 
F. Grases: The authors state that CaP can easily form 
in the distal tubuli . Can these crystals be dissolved as a 
consequence of the subsequent acidification of the urine? 
Authors: This issue is presently subject to experimental 
studies in our laboratory. Conclusive results are not yet 
available, but it is beyond every doubt that calcium 
phosphate crystals formed in this way can dissolve in 
acid urine. A pH of 5.95 is, however, apparently too 
high for such an effect. The type of calcium phosphate, 
its size and state of aggregation are probably important 
determinants in this respect. 
F. Grases: Which role do you think that CaP formed 
in the nephron has for CaOx stone formation? 
Authors: The answer to this question can only be spec-
ulative because the experiments carried out in our labo-
ratory so far have not been designed to address all as-
pects of this process. We believe, however, that crys-
tals of CaP formed in the nephron grow and aggregate 
to crystal masses of variable size. These crystal masses 
might provide a basis for the heterogeneous deposition 
of CaOx in the collecting ducts, probably in the distal 
part close to the papilla. An attractive view is that these 
crystals are adhered to the tubular surface and retained 
in this way during their further development. The mac-
romolecules might also play an important role for the 
crystal retention, but we have no experimental support 
for such an effect. 
A. Rogers: Why did you choose to use urine collected 
between the hours of 2400 and 0600 as opposed to a full 
I. H0jgaard et al. 
24-hour collection? 
Authors: For several years, an 8-hour night urine sam-
ple has been a part of our programme for investigation 
of stone formers. The main reason for introducing this 
collection period was to get a sample collected during a 
period sufficiently short to avoid compositional changes 
as a result of storage. These samples are taken care of 
within one or two hours following the completion of the 
collection. It appeared reasonable to apply these rou-
tines also to the normal subjects delivering urine for pre-
paration of urinary macromolecules. The night urine 
generally is more concentrated than the day urine and by 
using these samples inappropriate sample dilution was 
avoided. 
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A. Rogers: Why did you evaporate the urine samples 
to a pre-determined volume as opposed to a pre-deter-
mined osmolality? 
Authors: First, all the samples had a known ion-com-
position, and we do not think that there is any advantage 
of going the way over osmolality. Although this might 
be useful for samples with unknown composition, this is 
probably not so in this kind of experiments. Second, we 
were very interested in having a specific volume for 
calculation of the ion-activities. 
